title: Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluids.
abstract: Bactericidal activity of human beta-defensin 3 (hBD-3) against Streptococcus mutans and Actinobacillus actinomycetemcomitans was inhibited in a dose-dependent manner by the presence of saliva and/or serum. Increasing the concentration of hBD-3 partially overcame this inhibition. A fast bactericidal effect was observed against both bacterial strains, suggesting a potential therapeutic use for hBD-3 in the local treatment of oral infections.
authors.affiliation: Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia, University of Pisa, Via San Zeno 35-39, 56127 Pisa, Italy.
authors.forename: Giuseppantonio
authors.initials: G
authors.lastname: Maisetta
authors.forename: Giovanna
authors.initials: G
authors.lastname: Batoni
authors.forename: Semih
authors.initials: S
authors.lastname: Esin
authors.forename: Giorgio
authors.initials: G
authors.lastname: Raco
authors.forename: Daria
authors.initials: D
authors.lastname: Bottai
authors.forename: Flavia
authors.initials: F
authors.lastname: Favilli
authors.forename: Walter
authors.initials: W
authors.lastname: Florio
authors.forename: Mario
authors.initials: M
authors.lastname: Campa
mesh_terms: D016976:Aggregatibacter actinomycetemcomitans / Q000187:drug effects*; D000658:Amoxicillin / Q000494:pharmacology; D002710:Chlorhexidine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008826:Microbial Sensitivity Tests; D012463:Saliva / Q000276:immunology*; D013295:Streptococcus mutans / Q000187:drug effects*; D023083:beta-Defensins / Q000494:pharmacology*
chemical_list: C422950:DEFB103A protein, human; D023083:beta-Defensins; D000658:Amoxicillin; D002710:Chlorhexidine
references.citation: Antimicrob Agents Chemother. 2000 Jul;44(7):1803-8
references.pmid: 10858334
references.citation: Oral Microbiol Immunol. 2000 Aug;15(4):226-31
references.pmid: 11154407
references.citation: J Biol Chem. 2001 Feb 23;276(8):5707-13
references.pmid: 11085990
references.citation: Lancet Infect Dis. 2001 Oct;1(3):156-64
references.pmid: 11871492
references.citation: Nat Rev Immunol. 2003 Sep;3(9):710-20
references.pmid: 12949495
references.citation: J Biol Chem. 1998 Dec 11;273(50):33115-8
references.pmid: 9837875
references.citation: J Clin Microbiol. 2004 Mar;42(3):1024-9
references.pmid: 15004048
references.citation: J Oral Pathol Med. 2004 May;33(5):278-85
references.pmid: 15078488
references.citation: Am J Respir Cell Mol Biol. 1991 Aug;5(2):101-6
references.pmid: 1716445
references.citation: Eur J Epidemiol. 1993 Sep;9(5):483-8
references.pmid: 8307132
references.citation: Antimicrob Agents Chemother. 2003 Oct;47(10):3349-51
references.pmid: 14506056